Records 1 - 4 (of 4 Records)
|Query Trace: Recurrence and AKT2[original query]|
| Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71.
Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife
| Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.
Journal of cancer research and clinical oncology 2012 Mar 138 (3): 377-85.
Wang Li-E, Ma Hongxia, Hale Katherine S, Yin Ming, Meyer Larissa A, Liu Hongliang, Li Jie, Lu Karen H, Hennessy Bryan T, Li Xuesong, Spitz Margaret R, Wei Qingyi, Mills Gordon
| Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
Journal of Cancer 2018 9 (6): 1067-1077.
Peng Jianhong, Ma Wenjuan, Zhou Zhongguo, Gu Yangkui, Lu Zhenhai, Zhang Rongxin, Pan Zhizho
| Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Scientific reports 2023 11 13 (1): 19154.
Yeeun Lee, SeongRyeol Moon, Jae Yeon Seok, Joon-Hyop Lee, Seungyoon Nam, Yoo Seung Chu
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: